Avram Miller, Intel Capital co-founder, joins Renovaro board as advisor

Lunai Bioworks Inc.

Appointed Avram Miller to Board effective Oct 11, 2023; will serve until 2024 annual meeting.
Advisory agreement grants 1,000,000 restricted shares: 166,667 vest 2024, 444,444 in 2025, 388,889 in 2026.
Miller co-founded Intel Capital, has 13-year medical science background, advises Cleveland Clinic and Sheba Medical Center.

item 1.01 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Avram Miller

director

LNAI · Lunai Bioworks Inc.

Effective: 2023-10-11
Filed: October 11, 2023, 7:59 PM ET

appointed Avram Miller to the Board, effective October 11, 2023, to fill a vacancy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Avram Miller was appointed as director at Lunai Bioworks Inc..

Action: appointed
Role: director

Exact text from the filing

appointed Avram Miller to the Board, effective October 11, 2023, to fill a vacancy.

View on SEC.gov

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR

accession 0001731122-23-001860

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.